Projection of the number of patients with tuberculosis in the Netherlands in 2030

European Journal of Public Health

Volumn 19, Issue 4, 2009, Pages 424-427

  Van Leth, Frank ^a,b   Kalisvaart, Nico A ^b   Erkens, Connie G M ^b   Borgdoff, Martien W ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

Author keywords

Immigrants; Incidence; Life table; The Netherlands; Tuberculosis

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; NETHERLANDS; PRIORITY JOURNAL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FORECASTING; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NETHERLANDS; TUBERCULOSIS; YOUNG ADULT;

EID: 68449104155     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckp042     Document Type: Article

References (17)

1. Erkens CGM, Kalisvaart NA, Slump E, et al. Tuberculose in Nederland, Surveillancerapport over de tuberculosesituatie in Nederland [Tuberculosis in The Netherlands, Surveillance Report on the Situation Regarding Tuberculosis in The Netherlands]. The Hague: KNCV Tuberculosis Foundation, 2007.
2. Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284:2894-900.
3. Cain KP, Haley CA, Armstrong LR, et al. Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination. Am J Respir Crit Care Med 2007;175:75-9.
4. Li J, Roche P, Spencer J, et al. Tuberculosis notifications in Australia, 2003. Commun Dis Intell 2004;28:464-73.
5. Tuberculosis in Canada 2002: executive summary. Can Commun Dis Rep 2005;31:45-6.
6. Watera C, Todd J, Muwonge R, et al. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda. J Acquir Immune Defic Syndr 2006;42:373-8.
7. Global Tuberculosis Control: surveillance, planning, financing. Geneva, Switzerland: World Health Organization, 2007.
8. Erkens C, Slump E, Kamphorst M, et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur Respir J 2008;32:153-61.
9. Styblo K, Broekmans JF, Borgdorff MW. Expected decrease in the tuberculosis incidence during the elimination phase. How to determine its trend. In: TSRU, Progress Report. The Hague, The Netherlands: KNCV Tuberculosis Foundation, 1997.
10. Borgdorff MW, Nagelkerke N, van Soolingen D, et al. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol 1998;147:187-95.
11. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998;352:1886-91.
12. Sutherland I. Recent studies in the epidemiology of tuberculosis, based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976;19:1-63.
13. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119:183-201.
14. Wolleswinkel-van BJ, Nagelkerke NJ, Broekmans JF, Borgdorff MW. The impact of immigration on the elimination of tuberculosis in The Netherlands: a model based approach. Int J Tuberc Lung Dis 2002;6:130-6.
15. van Hest NA, Smit F, Baars HW, et al. Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis? Epidemiol Infect 2007;135:1021-9.
16. Borgdorff MW, Nagelkerke NJ, van Soolingen D, Broekmans JF. Transmission of tuberculosis between people of different ages in The Netherlands: an analysis using DNA fingerprinting. Int J Tuberc Lung Dis 1999;3:202-6.
17. Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007;11:16-26.